Patient Support Services Contact Us
Image: Coherus Investors


 View printer-friendly version << Back
January 5, 2021 at 4:01 PM EST

Coherus BioSciences Management to Present at the 39th Annual J.P. Morgan Healthcare Conference

REDWOOD CITY, Calif., Jan. 05, 2021 (GLOBE NEWSWIRE) -- Coherus BioSciences, Inc. (“Coherus”, Nasdaq: CHRS), today announced that senior management will present at the virtual 39th Annual J.P. Morgan Healthcare Conference on Monday, January 11, 2021 at 10:50 a.m. EST / 7:50 a.m. PST.

The audio portion of the Company presentation will be available on the investors page of the Coherus BioSciences website at

About Coherus BioSciences, Inc.

Coherus is a leading commercial-stage biosimilar company dedicated to expanding access to high-quality therapeutics that can have a major impact on patients’ lives and to delivering significant savings to the health care system. For additional information, please visit


McDavid Stilwell
EVP, Corporate Development, IR and Financial Strategy
Coherus BioSciences,
+1 (650) 395-0152

Primary Logo

Source: Coherus BioSciences, Inc.